Acessibilidade / Reportar erro

Agreement between RAPD, API20C AUX, CHROMagar Candida and microculture on oral Candida identification

Abstract

Aim:

To measure the agreement of methods for identification of Candida species in oral cavity samples, comparing the CHROMagar Candida, microculture, API 20C AUX and RAPD techniques.

Methods:

Ninety-one colonies of Candida were isolated and presumptively identified in CHROMagar Candida, submitted to microculture, API 20C AUX and RAPD techniques. After this, agreement among methods using Kappa test was performed.

Results:

Agreement rates between RAPD and CHROMagar Candida, showed significant accuracy for C. albicans, C. tropicalis, C. dubliniensis and C. krusei (Kappa: 0.760, 0.640, 0.416 and 0.360, respectively, p<0.05). Comparing RAPD results with microculture, the highest agreement was for C. albicans (Kappa: 0.851 - p<0.05) but no significant agreement for C. lusitaniae, C. krusei and C. guilliermondii was obtained (p>0.05). The agreement was significant for all identified species when RAPD (OPE-18) and API 20C AUX (p<0.05) were used. Critical levels of agreement between RAPD and microculture were observed when C. lusitaniae, C. krusei and C. guilliermondii were identified.

Conclusions:

API 20C AUX presented the best agreement with molecular random identification and CHROMagar showed good agreement for C. albicans, C. tropicalis, C. dubliniensis and C. krusei identification.

candida; mouth; methods


Introduction

Candida species are commensal microorganisms of the oral cavity. They have several virulence factors, which in the presence of local and systemic host failures may result in their transition from commensal to pathogenic organisms1Rossoni RD, Barbosa JO, Vilela SFG, Santos JDD, Jorge AOC, Junqueira JC. Correlation of phospholipase and proteinase production of Candida with in vivo pathogenicity in Galleria mellonella. Braz J Oral Sci. 2013;12, 199-204., causing oral and systemic infections that pose significant public health problems. Their isolation is used in investigations related to salivary disfunction, oral candidiasis, orofacial pathologies, and immune suppressant status2Beighton D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, et al. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol. 1995; 33: 3025-7.

Reichart PA, Samaranayake LP, Samaranayake YH, Grote M, Pow E, Cheung B. High oral prevalence of Candida krusei in leprosy patients in Northern Thailand. J Clin Microbiol. 2002; 40: 4479-85.
- 4Alnuaimi AD, Wiesenfeld D, O'Brien-Simpson NM, Reynolds EC, Peng B, McCullough MJ. The development and validation of a rapid genetic method for species identification and genotyping of medically important fungal pathogens using high-resolution melting curve analysis. Molecular Oral Microbiology.2014; 29: 117-130..

There is a variety of methods for identifying Candida species from clinical samples in the oral cavity5Neppelenbroek KH, Seó RS, Urban VM, Silva S, Dovigo LN, Jorge JH, et al. Identification of Candida species in the clinical laboratory: a review of conventional, commercial, and molecular techniques. Oral Diseases. 2014; 20: 329-44.. The CHROMagar Candida differential medium is commonly used to isolate and identify presumptive C. albicans, C. dubliniensis, C. tropicalis and C. krusei. Their sensitivity and specificity are considered satisfactory for these species2Beighton D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, et al. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol. 1995; 33: 3025-7. , 6Da Costa K, Ferreira J, Komesu M, Candido R. Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity. Mycopathologia. 2009; 167: 73-9. - 7Yücesoy M, Marol S. Performance of CHROMagar Candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob. 2003; 2: 1-7..

The microculture analysis has considerable accuracy and presents low cost2Beighton D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, et al. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol. 1995; 33: 3025-7., but it requires visual experience, sometimes limited by the resolution of optical microscopy and confused by similarities among species' expressions. The biochemical characterization could be performed using the API(r) 20C AUX (BioMerieux, France) which relies on variations in the assimilation of carbohydrates7Yücesoy M, Marol S. Performance of CHROMagar Candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob. 2003; 2: 1-7.

Hata DJ, Hall L, Fothergill AW, Larone DH, Wengenack NL. Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identiûcation card. J Clin Microbiol. 2007; 45: 1087-92.
- 9Smith M, Dunklee D, Hangna V, Woods G. Comparative performance of the RapID yeast plus system and the API 20C AUX clinical yeast system. J Clin Microbiol. 1999; 37: 2697-8.. However, it presents limitations related to cost and to distinguish between some species2Beighton D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, et al. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol. 1995; 33: 3025-7.. A study of 159 clinical isolates of Candida species identified by the very similar kit API(r) Candida AUX (BioMerieux, Marcy l'Etoile, France) reported that 12 isolates (7.5%) were incorrectly identified1010 Ramani R, Gromadzki S, Pincus DH, Salkin IF, Chaturvedi V. Efficacy of API 20C and ID 32C Systems for identification of common and rare clinical yeast isolates. J Clin Microbiol. 1998; 36 : 3396-8. - 1111 Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol. 2007; 24: 148-51..

In recent decades, traditional methods of microorganism phenotyping have been replaced or added by the procedures associated to recombinant DNA1212 Sullivan DJ, Henman MC, Moran GP, O'Neill LC, Bennett DE, Shanley DB, et al. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microbiol. 1996; 44: 399-408.

13 Elie CM, Lott TJ, Reiss E, Morrison CJ. Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol. 1998; 36: 3260-5.
- 1414 Joly S, Pujol C, Rysz M, Vargas K, Soll DR. Development and Characterization of Complex DNA Fingerprinting Probes for the Infectious Yeast Candida dubliniensis. J Clin Microbiol. 1999; 37: 1035-44.. Methods based on molecular markers are useful not only for phenotyping, but also for differentiation of Candida species1515 Neppelenbroek KH, Campanha NH, Spolidorio DM, Spolidorio LC, Seó RS, Pavarina AC. Molecular fingerprinting methods for the discrimination between C. albicans and C. dubliniensis. Oral Dis. 2006; 12: 242-53. - 1616 Ahmad S, Khan Z, Asadzadeh M, Theyyathel A, Chandy R. Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis. BMC Infectious Diseases. 2012; 12: 230.. The RAPD (Random Amplification Polymorphic DNA) allows the amplification of DNA sequences and is a simple and quick technique that does not require prior knowledge on the genomes to characterize organisms, using one randomly determined (usually a decamer) primer1717 Babu KN, Rajesh MK, Samsudeen K, Minoo D, Suraby EJ, Anupama K, et al. Randomly amplified polymorphic DNA (RAPD) and derived techniques. Methods Mol Biol. 2014; 1115: 191-209.. It is used for genetic characterization of a range of organisms, plants, animals or microorganisms, including Candida species, for different purposes1818 Mucciarelli M, Ferrazzini D, Belletti P. Genetic variability and population divergence in the rare Fritillaria tubiformis subsp. Moggridgei rix (Liliaceae) as revealed by RAPD analysis. PLoS One. 2014; 9 :e101967.

19 Yuan G, Sun J, Li H, Fu G, Xu G, Li M, et al. Identification of velvet antler by random amplified polymorphism DNA combined with non-gel sieving capillary electrophoresis. Mitochondrial DNA. 2014; 8: 1-7.

20 Paluchowska P, Tokarczyk M, Bogusz B, Skiba I, Budak A. Molecular epidemiology of Candida albicans and Candida glabrata strains isolated from intensive care unit patients in Poland. Mem Inst Oswaldo Cruz. 2014; 109: 436-41.
- 2121 Nielsen KL, Godfrey PA, Stegger M, Andersen PS, Feldgarden M, Frimodt Møller N. Selection of unique Escherichia coli clones by random amplified polymorphic DNA (RAPD): Evaluation by whole genome sequencing. J Microbiol Methods. 2014; 103: 101-3.. The sensitivity, specificity and resolution of the OPE-18 primer for identification of Candida species has been reported and could be used for epidemiological Candida identification1111 Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol. 2007; 24: 148-51. , 2222 Bautista-Muñoz C, Boldo X, Villa-Tanaca L, Hernández-Rodríguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol. 2003; 41: 414-20..

Due to scarce information about presumptive, biochemical and molecular agreement on Candida identification, this study aimed to measure the assertive correlation between the presumptive identification of Candida species from oral cavity using CHROMagar Candida, microculture, API(r) 20C Aux and OPE-18 genotyping.

Material and methods

Ethical procedures

Ethical considerations in accordance with Helsinki Declaration have been observed. This research was conducted according to the ethical principles of research involving human participants, as stipulated by Resolution 196/96 of the National Health Council of the Ministry of Health of Brazil. The collection and analysis of data in this study were certified by the research ethics committee of the State University of Montes Claros, MG, Brazil, protocol CEP nº. 1111/08.

Origin of samples

The Candida isolates resulted from salivary collections of oral cavity of patients irradiated on head and neck due to malignant neoplasms (n=29) and elderly volunteers (n=63). The collection comprised 91 isolates of Candida species.

Isolation and presumptive identification of Candida species

The isolation of yeasts was made in salivary samples collected from the buccal mucosa and tongue with a swab and sterile saline solution (NaCl, 0.85%) as diluent. The isolation and presumptive identification was made by drawing aliquots (100 µL) from each sample and placing them on plates containing CHROMagar Candida and incubated at 37 °C for 24 to 48 h, in duplicate. Yeast identification was made by considering the morphology and color of the colonies2Beighton D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, et al. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol. 1995; 33: 3025-7. , 2323 Koehler AP, Chu K-C, Houang ETS, Cheng AFB. Simple, reliable and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol. 1999; 37: 422-6.. Each colony of Candida was cataloged and then stored at -20 °C in Sabouraud Dextrose Broth (DSB, Oxoid Ltd., London, England) amended with glycerol (40% v/v). ATCC 10231 of C. albicans was used as quality control (QC).

Microculture characterization of isolates

Microcultures with Cornmeal Agar-Tween 80 (Rheum, Lenexa, KS, USA)23 23 Koehler AP, Chu K-C, Houang ETS, Cheng AFB. Simple, reliable and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol. 1999; 37: 422-6.were made to highlight blastospores, chlamydospores, pseudohyphae and true hyphae of the isolates. To differentiate C. albicans and C. dubliniensis from other Candida species, germ tube production was viewed on bovine serum2424 Odds FC. Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts. J Clin Microbiol. 1991; 29: 2735-40. - 2525 Bernal S, Martín Mazuelos E, García M, Aller AI, Martínez MA, Gutiérrez M. Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis. 1996. 24: 201-4.. To distinguish C. albicans from C. dubliniensis, cultivation on Sabouraud Dextrose Agar (Oxoid, Hampshire, England) for 48 h was made at 42 °C, using ATCC 10231 as QC.

Identification by API 20C AUX

The inoculum used to this procedure was obtained from cultured yeast on Sabouraud Agar. The procedures for inoculation and interpretation were performed according to the instructions provided by the manufacturer (BioMerieux, France). Identification list on these indexes was considered as excellent (%ID≥99.9, T≥0.75), very good (≥99.0% ID and T≥0.5) or acceptable (%ID≥90.0 and T ≥0.5)7Yücesoy M, Marol S. Performance of CHROMagar Candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob. 2003; 2: 1-7..

Identification of isolates by RAPD (Random Amplification Polymorphic DNA)

The extraction and purification of DNA from isolates of Candida spp was made with the Purelink Genomic DNA(r) kit (Invitrogen K1820-02, Brazil). The used DNA was obtained from cells grown in YPD broth (1% Malt Extract Powder, 2% bacteriological peptone and 2% dextrose - D-glucose) at 37 °C and shaking (150 rpm for 24 h)1111 Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol. 2007; 24: 148-51.. A total of 50 µL of concentrated suspension of each isolate was obtained by centrifugation (3,500 rpm for 30 min). The purification of DNA was made by adding 200 µL of digestion buffer, 20 µL proteinase K and 20 µL RNase. We added to 200 µL of binding buffer and then the tubes were heated for 10 min at 80 °C in a water bath. To neutralize the detergent and to allow the connection with the silica column, 200 µL of absolute ethanol was added (Merck, Darmstadt, Germany). The tubes were centrifuged at 13,000 rpm for 1 min and the pellet was discarded. Subsequently were added 500 µL of the first washing buffer and centrifuged again at 13,000 rpm for 1 min and the precipitate discarded. The column with the silica was passed to the second tube and added 500 µL of the second washing buffer and centrifuged to 13,000 rpm for 1 min and for 3 additional minutes to enhance drying.

For the first extraction, 200 µL of sterile water were added to Milli-Q heated to 60 °C in the column in a second tube. Then it was centrifuged at 13,000 rpm for 1 min. For the second extraction, 200 μL of elution buffer of the same column were placed in a third tube and centrifuged it at 13,000 rpm for 1 min.

The products of RAPD-PCR were obtained with OPE-18 primer (5'-GGACTGCAGA-3') (Gibco BRL, Grand Island, NY, USA). The preparation of reactions for each isolate was done by adding 1 μL of primer, 5 μL of dNTP mix (dATP, dCTP, and dTTP DGPT - Invitrogen, Brazil), 2.5 μL 10x PCR Buffer Rxn, 1 μL MgCl2 (50 mM), 0.5 μL Taq DNA polymerase (2.5 U - Invitrogen Platinum(r), Brazil) and 5.5 μL Milli-Q. The final volume was 25 μL, 15 μL of MIX and 10 ìL of extracted DNA. The amplification consisted of 39 one-minute cycles at 94 °C, 1 min at 36 °C, 2 min at 72 °C followed by a 10 min cycle at 72 °C1111 Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol. 2007; 24: 148-51..

PCR products were separated by agarose gel eletroforesis (1.4% / v - 5μL ethidium bromide - 10 mg/mL), 80 V for 5 h. We used ATCC 10231 as QC and two molecular weights were incorporated (100 bp and 250 bp - Invitrogen, São Paulo, SP, Brazil). The DNA bands were observed and photographed in transillumination and the images were analyzed considering the literature reports1111 Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol. 2007; 24: 148-51. , 2222 Bautista-Muñoz C, Boldo X, Villa-Tanaca L, Hernández-Rodríguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol. 2003; 41: 414-20..

Table 1 shows comparison of the methods used in this study.

Table 1
Comparation of methods used in this study.

Results

Among the 91 isolates, C. albicans was the most prevalent, identified presumptively in 35 (38.5%) of colonies by CHROMagar Candida. On the confirmatory identification, 31 (34.1%) of these isolates were confirmed on microculture as C. albicans, while 30 (32.9%) were confirmed by the API 20C Aux(r) and 29 (31.9%) by RAPD. RAPD identified 29 (31.9%) C. albicans, 4 (4.4%) C. dubliniensis, 10 (10.9%) C. tropicalis, 9 (9.9%) C. krusei, 12 (13.2%) C. glabrata, 9 (9.9%) C. parapsilosis, 6 (6.6%) C. guilliermondii, 6 (6.6%) C. lusitaniae and 5 (5.5%) C. kefyr. Figure 1 shows RAPD with different species of Candida.

Fig. 1
RAPD showing different species of Candida. (1) Ladder (250 pb), (2) C. albicans ATCC,(3) C. albicans ATCC, (4) C. tropicalis; (5) C. krusei, (6) C. albicans ATCC, (7) C. guilliermondii, (8) C. albicans.

The CHROMagar Candida(r) presumptively identified 28 (30.8%) of isolates as other Candida species (C. dubliniensis, C. tropicalis, and C. krusei). The agreement between genetic typing and CHROMagar Candida(r) was higher for C. albicans and lower for C. krusei. Table 2 shows the agreement coefficient (Kappa) between RAPD (OPE-18) and CHROMagar Candida.

Table 2
Kappa coefficient between the presumptive identification of Candida species by CHROMagar Candida and RAPD (OPE18)

In the RAPD technique only one isolate (1.1%) presented an undefined pattern, followed by five (5.5%) in API 20C AUX(r) and 8 (8.8%) in microculture. Considering the comparative analysis between the RAPD characterization and microculture evaluation, we can observe that the identifications of C. albicans, C. dubliniensis, C. tropicalis, C. glabrata, C. kefyr and C. parapsilosis were significantly concordant in decreasing levels among the methods, in that order. When RAPD and API 20C AUX(r) were compared, the species C. tropicalis, C. albicans, C. glabrata, C. kefyr, C. dubliniensis, C. lusitaniae, C. krusei and C. guilliermondii showed significant decreasing agreement, in that order. Table 3 shows the Kappa coefficient among RAPD, API 20C AUX and microculture.

Table 3
Kappa coefficient applied to comparative identification between API(r) 20C AUX and microculture analysis with reference to the products of RAPD (OPE 18)

Discussion

The presumptive identification of yeasts may be crucial in the diagnosis and treatment of fungal infections. It is a fundamental recognition and validation of methods that should be fast, accurate and inexpensive. Bernal et al.2525 Bernal S, Martín Mazuelos E, García M, Aller AI, Martínez MA, Gutiérrez M. Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis. 1996. 24: 201-4. (1996) using the CHROMagar Candida for presumed identification of 593 colonies, revealed 341 (57.5%) C. albicans, 339 (57.2%) of them featuring green characteristic color. All 35 (5.9%) C. krusei and 73 (12.3%) of C. tropicalis presented specific characteristics identified on CHROMagar Candida. In the present study, among the 91 isolates, 35 (38.46%) were pale green, 18 (30.7%) pale pink with white halo and 5 (5.5%) were blue on CHROMagar Candida. Using RAPD, 29 (31.8%) were identified as C. albicans, 8(8.8%) as C. krusei and 9 (9.9%) as C. tropicalis (Kappa coefficient 0.760, 0.360 and 0.640 respectively - p<0.05), showing a good accuracy of CHROMagar Candida identification of these species.

Studies with OPE-18 primer1111 Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol. 2007; 24: 148-51. , 22 22 Bautista-Muñoz C, Boldo X, Villa-Tanaca L, Hernández-Rodríguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol. 2003; 41: 414-20.showed different monomorphic bands for the species C. glabrata, C. guilliermondii and C. lusitaniae. Baires-Varguez et al.1111 Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol. 2007; 24: 148-51.(2007) using OPE 18 by RAPD-PCR with 92 clinical isolates revealed 20 (21.7%) C. albicans, 14 (15.2%) C. glabrata, 10 (10.9%) C. guilliermondii, 11 (11.95%) C. lusitaniae and 15 (16.3%) C. tropicalis with a 91% sensitivity for the total isolates, being very specific and sensitive for the C. glabrata, C. guilliermondii,C. tropicalis, C. pelliculosa, C. albicans, C. krusei and C. lusitaniae species. Among the 91 isolates in the analysis using the same technique and the same primer, were obtained 29 (31.9%) C. albicans, 12 (13.2%) C. glabrata, 6 (6.6%) C. guilliermondii and 6 (6.6%) C. lusitaniae. The sensitivity and specificity in the present study was respectively 96% and 97% for C. albicans, 80% and 100% for C. glabrata, 89% and 95% for C. parapsilosis and 100% and 98% for C. tropicalis.

Several studies used the API(r) 20C AUX as identification and confirmation of Candida species2626 Silva J, Candido R. Evaluation of the API20C AUX system for the identification of clinically important yeasts. Rev Soc Bras Med Trop. 2005; 38: 261-3.

27 Sand C, Rennie R. Comparison of three commercial systems for the identification of germ-tube negative yeast species isolated from clinical specimens. Diagn Microbiol Infect Dis. 1999; 33: 223-9.
- 2828 Kirkpatrick WR, Revankar SG, McAtee RK, Lopez-Ribot JL, Fothergill AW, McCarthy DI, et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol. 1998; 36: 3007-12.. Silva and Candido2626 Silva J, Candido R. Evaluation of the API20C AUX system for the identification of clinically important yeasts. Rev Soc Bras Med Trop. 2005; 38: 261-3. (2005) using the API(r) 20C AUX identified 92% (46) of yeasts used in their study, 76% (38) did not require additional tests and 16% (8) required some additional analysis. The results are closer to Sand and Rennie2727 Sand C, Rennie R. Comparison of three commercial systems for the identification of germ-tube negative yeast species isolated from clinical specimens. Diagn Microbiol Infect Dis. 1999; 33: 223-9. (1999), who found 96.5% accuracy after 72 h. Good results were also obtained by Smith et al.9Smith M, Dunklee D, Hangna V, Woods G. Comparative performance of the RapID yeast plus system and the API 20C AUX clinical yeast system. J Clin Microbiol. 1999; 37: 2697-8. (1999), who found 95.6% of identification without extra tests. In this analysis, among the 91 isolates, RAPD identified 12 (13.2%) C. glabrata, 9 (9.9%) C. parapsilosis, 6 (6%) C. guilliermondii, 6 (6%) C. lusitaniae and 5 (5.5%) C. kefyr. When the same species were submitted to the API(r) 20C AUX, the agreement was statistically significant (p<0.05).

The agreement between RAPD (OPE-18) and API(r) 20C AUX is evidently higher. Critical levels of agreement between RAPD and microcultive were observed when C. lusitaniae, C. krusei and C. guilliermondii were identified. For presumptive identification, CHROMagar Candida is adequate for C. albicans, C. dubliniensis, C. tropicalis and C. krusei identification.

Acknowledgements

We would like to thank the Foundation for Research Support of Minas Gerais - FAPEMIG - Minas Gerais and CNPq, Brazil, for the financial support provided to our research and we also wish to thank Marise Silveira for the biostatistical services.

References

  • 1
    Rossoni RD, Barbosa JO, Vilela SFG, Santos JDD, Jorge AOC, Junqueira JC. Correlation of phospholipase and proteinase production of Candida with in vivo pathogenicity in Galleria mellonella. Braz J Oral Sci. 2013;12, 199-204.
  • 2
    Beighton D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, et al. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol. 1995; 33: 3025-7.
  • 3
    Reichart PA, Samaranayake LP, Samaranayake YH, Grote M, Pow E, Cheung B. High oral prevalence of Candida krusei in leprosy patients in Northern Thailand. J Clin Microbiol. 2002; 40: 4479-85.
  • 4
    Alnuaimi AD, Wiesenfeld D, O'Brien-Simpson NM, Reynolds EC, Peng B, McCullough MJ. The development and validation of a rapid genetic method for species identification and genotyping of medically important fungal pathogens using high-resolution melting curve analysis. Molecular Oral Microbiology.2014; 29: 117-130.
  • 5
    Neppelenbroek KH, Seó RS, Urban VM, Silva S, Dovigo LN, Jorge JH, et al. Identification of Candida species in the clinical laboratory: a review of conventional, commercial, and molecular techniques. Oral Diseases. 2014; 20: 329-44.
  • 6
    Da Costa K, Ferreira J, Komesu M, Candido R. Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity. Mycopathologia. 2009; 167: 73-9.
  • 7
    Yücesoy M, Marol S. Performance of CHROMagar Candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob. 2003; 2: 1-7.
  • 8
    Hata DJ, Hall L, Fothergill AW, Larone DH, Wengenack NL. Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identiûcation card. J Clin Microbiol. 2007; 45: 1087-92.
  • 9
    Smith M, Dunklee D, Hangna V, Woods G. Comparative performance of the RapID yeast plus system and the API 20C AUX clinical yeast system. J Clin Microbiol. 1999; 37: 2697-8.
  • 10
    Ramani R, Gromadzki S, Pincus DH, Salkin IF, Chaturvedi V. Efficacy of API 20C and ID 32C Systems for identification of common and rare clinical yeast isolates. J Clin Microbiol. 1998; 36 : 3396-8.
  • 11
    Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol. 2007; 24: 148-51.
  • 12
    Sullivan DJ, Henman MC, Moran GP, O'Neill LC, Bennett DE, Shanley DB, et al. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microbiol. 1996; 44: 399-408.
  • 13
    Elie CM, Lott TJ, Reiss E, Morrison CJ. Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol. 1998; 36: 3260-5.
  • 14
    Joly S, Pujol C, Rysz M, Vargas K, Soll DR. Development and Characterization of Complex DNA Fingerprinting Probes for the Infectious Yeast Candida dubliniensis. J Clin Microbiol. 1999; 37: 1035-44.
  • 15
    Neppelenbroek KH, Campanha NH, Spolidorio DM, Spolidorio LC, Seó RS, Pavarina AC. Molecular fingerprinting methods for the discrimination between C. albicans and C. dubliniensis. Oral Dis. 2006; 12: 242-53.
  • 16
    Ahmad S, Khan Z, Asadzadeh M, Theyyathel A, Chandy R. Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis. BMC Infectious Diseases. 2012; 12: 230.
  • 17
    Babu KN, Rajesh MK, Samsudeen K, Minoo D, Suraby EJ, Anupama K, et al. Randomly amplified polymorphic DNA (RAPD) and derived techniques. Methods Mol Biol. 2014; 1115: 191-209.
  • 18
    Mucciarelli M, Ferrazzini D, Belletti P. Genetic variability and population divergence in the rare Fritillaria tubiformis subsp. Moggridgei rix (Liliaceae) as revealed by RAPD analysis. PLoS One. 2014; 9 :e101967.
  • 19
    Yuan G, Sun J, Li H, Fu G, Xu G, Li M, et al. Identification of velvet antler by random amplified polymorphism DNA combined with non-gel sieving capillary electrophoresis. Mitochondrial DNA. 2014; 8: 1-7.
  • 20
    Paluchowska P, Tokarczyk M, Bogusz B, Skiba I, Budak A. Molecular epidemiology of Candida albicans and Candida glabrata strains isolated from intensive care unit patients in Poland. Mem Inst Oswaldo Cruz. 2014; 109: 436-41.
  • 21
    Nielsen KL, Godfrey PA, Stegger M, Andersen PS, Feldgarden M, Frimodt Møller N. Selection of unique Escherichia coli clones by random amplified polymorphic DNA (RAPD): Evaluation by whole genome sequencing. J Microbiol Methods. 2014; 103: 101-3.
  • 22
    Bautista-Muñoz C, Boldo X, Villa-Tanaca L, Hernández-Rodríguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol. 2003; 41: 414-20.
  • 23
    Koehler AP, Chu K-C, Houang ETS, Cheng AFB. Simple, reliable and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol. 1999; 37: 422-6.
  • 24
    Odds FC. Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts. J Clin Microbiol. 1991; 29: 2735-40.
  • 25
    Bernal S, Martín Mazuelos E, García M, Aller AI, Martínez MA, Gutiérrez M. Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis. 1996. 24: 201-4.
  • 26
    Silva J, Candido R. Evaluation of the API20C AUX system for the identification of clinically important yeasts. Rev Soc Bras Med Trop. 2005; 38: 261-3.
  • 27
    Sand C, Rennie R. Comparison of three commercial systems for the identification of germ-tube negative yeast species isolated from clinical specimens. Diagn Microbiol Infect Dis. 1999; 33: 223-9.
  • 28
    Kirkpatrick WR, Revankar SG, McAtee RK, Lopez-Ribot JL, Fothergill AW, McCarthy DI, et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol. 1998; 36: 3007-12.

Publication Dates

  • Publication in this collection
    Apr-Jun 2015

History

  • Received
    10 Mar 2015
  • Accepted
    19 June 2015
Faculdade de Odontologia de Piracicaba - UNICAMP Avenida Limeira, 901, cep: 13414-903, Piracicaba - São Paulo / Brasil, Tel: +55 (19) 2106-5200 - Piracicaba - SP - Brazil
E-mail: brjorals@unicamp.br